- Hem
- Böcker
- Kurslitteratur
- Vård, Omsorg & Medicin
- Hepatobiliary Cancers: Translational Advances and Molecular Medicine (inbunden, eng)

Hepatobiliary Cancers: Translational Advances and Molecular Medicine (inbunden, eng)
Hepatobiliary cancer refers to primary malignant tumors originating in cells of the liver, bile ducts, and gallbladder. Globally, primary li...
1 989 kr
Bara 2 kvar
Skickas inom 4 - 5 vardagar
- Fri frakt
Just nu: Fri frakt på alla köp
Snabb leverans
Alltid låga priser
Produktbeskrivning
Hepatobiliary cancer refers to primary malignant tumors originating in cells of the liver, bile ducts, and gallbladder. Globally, primary liver cancer, which includes hepatocellular carcinoma (~75 % of all cases) and intrahepatic biliary cancer or cholangiocarcinoma (~10-15 % 0f all cases) is the 6th most commonly diagnosed cancer and 3rd leading cause of cancer deaths worldwide.
The vast majority of these highly malignant cancers are diagnosed at an advanced stage where treatment options are limited and patient survival outcomes are poor. The biological and therapeutic challenges posed by hepatobililiary cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are daunting, emphasizing a critical need to review and assess current and evolving basic, translational, and clinical research focused on addressing the critical obstacles that continue to limit progress towards achieving significant improvements in HCC and CCA clinical management and patient survival outcomes.
Towards this goal, this special edition of Advances in Cancer Research is focused on providing a comprehensive, timely and authoritative reviews covering such topics of significant scientific and clinical relevance, including hepatobiliary cancer risk mechanisms and risk-predictive molecular biomarkers; causes and functional intricacies of inter- and intratumor heterogeneity; novel insights into the role of tumor microenvironment and key signaling pathways in promoting hepatobiliary cancer progression, therapeutic resistance and immunosuppression; emerging biomarkers of HCC and CCA prognosis; advances in molecular genomics for personalizing tumor classification and targeted therapies; innovative preclinical cell culture modeling for hepatobiliary cancer drug discovery; and current and emerging trends in hepatobiliary cancer molecular therapeutic targeting and immunotherapies.
The vast majority of these highly malignant cancers are diagnosed at an advanced stage where treatment options are limited and patient survival outcomes are poor. The biological and therapeutic challenges posed by hepatobililiary cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are daunting, emphasizing a critical need to review and assess current and evolving basic, translational, and clinical research focused on addressing the critical obstacles that continue to limit progress towards achieving significant improvements in HCC and CCA clinical management and patient survival outcomes.
Towards this goal, this special edition of Advances in Cancer Research is focused on providing a comprehensive, timely and authoritative reviews covering such topics of significant scientific and clinical relevance, including hepatobiliary cancer risk mechanisms and risk-predictive molecular biomarkers; causes and functional intricacies of inter- and intratumor heterogeneity; novel insights into the role of tumor microenvironment and key signaling pathways in promoting hepatobiliary cancer progression, therapeutic resistance and immunosuppression; emerging biomarkers of HCC and CCA prognosis; advances in molecular genomics for personalizing tumor classification and targeted therapies; innovative preclinical cell culture modeling for hepatobiliary cancer drug discovery; and current and emerging trends in hepatobiliary cancer molecular therapeutic targeting and immunotherapies.
Format | Inbunden |
Omfång | 466 sidor |
Språk | Engelska |
Förlag | Elsevier Science & Technology |
Utgivningsdatum | 2022-08-18 |
ISBN | 9780323983921 |
Specifikation
Böcker
- Format Inbunden
- Antal sidor 466
- Språk Engelska
- Utgivningsdatum 2022-08-18
- ISBN 9780323983921
- Förlag Elsevier Science & Technology
Leverans
Vi erbjuder flera smidiga leveransalternativ beroende på ditt postnummer, såsom Budbee Box, Early Bird, Instabox och DB Schenker. Vid köp över 399 kr är leveransen kostnadsfri, annars tillkommer en fraktavgift från 39 kr. Välj det alternativ som passar dig bäst för en bekväm leverans.
Betalning
Du kan betala tryggt och enkelt via Avarda med flera alternativ: Swish för snabb betalning, kortbetalning med VISA eller MasterCard, faktura med 30 dagars betalningstid, eller konto för flexibel delbetalning.
Specifikation
Böcker
- Format Inbunden
- Antal sidor 466
- Språk Engelska
- Utgivningsdatum 2022-08-18
- ISBN 9780323983921
- Förlag Elsevier Science & Technology